Destructive Effects of Prenatal WIN 55212-2 Exposure on Central Nervous System of Neonatal Rats
Background: Cannabinoid, particularly hashish and WIN 55212-2 (WIN), consumption during embryonic period may affect fetal growth, and the development of motor functioning, memory and cognitive functions. Therefore, the present study aimed to evaluate the effects of WIN 55212-2 during embryonic perio...
Main Authors: | Mohammad Shabani, Kouros Divsalar, Mahyar Janahmadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Kerman University of Medical Sciences
2012-07-01
|
Series: | Addiction and Health |
Online Access: | https://ahj.kmu.ac.ir/article_84573_bc29c81857d74d4b04a44c60d8ae918a.pdf |
Similar Items
-
Microinjection of WIN55,212-2 as a Cannabinoid Agonist into the Basolateral Amygdala Induces Sensitization to Morphine in Rats
by: Marzieh Molaei, et al.
Published: (2014-11-01) -
Minimum Alveolar Concentration of Isoflurane in Rats Chronically Treated with the Synthetic Cannabinoid WIN 55,212-2
by: Julio Raul Chavez-Monteagudo, et al.
Published: (2022-03-01) -
The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats
by: Samane Jahanabadi, et al.
Published: (2016-04-01) -
Alterations in Rat Accumbens Dopamine, Endocannabinoids and GABA Content During WIN55,212-2 Treatment: The Role of Ghrelin
by: Chrysostomos Charalambous, et al.
Published: (2020-12-01) -
Role of Nitric Oxide in the Antipruritic Effect of WIN 55,212-2, a Cannabinoid Agonist
by: Oyku Zeynep Gercek, et al.
Published: (2020-07-01)